// All site content lives here. Edit freely.

export const person = {
  name: "Dr. Christoph P. Freier",
  shortName: "Dr. C. P. Freier",
  title: "PharmD, PhD",
  tagline: "Building rigorous AI for healthcare: From Scientific Depth to Real-World Systems.",
  bio: `I operate at the intersection of AI, clinical data, and real-world healthcare systems, focusing on turning complex scientific and regulatory environments into solutions that actually work in practice.

Over the past decade, I have worked across 20+ countries in Europe and the US, contributing to the development and commercialization of data-driven platforms in life sciences and healthcare. My work sits at the interface of product, engineering, and commercial teams, with ownership ranging from technical delivery to €M-scale market activities.

My background combines scientific research, software development, and client-facing roles across consulting, pre-sales, and solution delivery. This allows me to move from first principles to production systems and to navigate the constraints that typically prevent AI from delivering real impact.

Most AI in healthcare fails not because of models, but because of systems. Regulatory constraints, fragmented data, and organisational complexity define the real problem.

I focus on building AI-enabled systems that work within those constraints — from strategy and architecture to execution and adoption.`,
  location: "Berlin, Germany",
  email: "christoph@freier.fr",
  linkedin: "https://www.linkedin.com/in/christophfreier",
  github: "https://github.com/Kawameicha",
};

export const pillars = [
  {
    title: "Scientific & Clinical Depth",
    description:
      "PharmD and PhD in immuno-oncology with over a decade of experience across life sciences, clinical workflows, and high-dimensional biomedical data. I understand the scientific and regulatory context in which AI must operate.",
    icon: "flask-conical",
  },
  {
    title: "AI & Data Systems",
    description:
      "From single-cell analytics to GenAI-enabled workflows, I design and deliver robust data architectures, machine learning pipelines, and production-grade systems built for real-world complexity.",
    icon: "network",
  },
  {
    title: "Product & Market Execution",
    description:
      "Bridging product, engineering, and commercial teams across Europe and the US. From prototype to adoption, I turn technical capability into systems that create measurable impact.",
    icon: "target",
  },
  {
    title: "Strategy & Leadership",
    description:
      "Senior stakeholder alignment, team leadership, and execution in regulated environments. I help organisations define what should be built, why it matters, and how to make it work at scale.",
    icon: "compass",
  },
];

export const projects = [
  {
    slug: "flowjo-plugin-single-cell-analysis",
    title: "Scaling Single-Cell Analysis Beyond Manual Workflows",
    year: "2019 – Present",
    featured: true,
    oneLiner:
      "Custom analytical tooling to extend FlowJo for high-dimensional single-cell data and enable reproducible workflows.",
      
    context:
      "During the rapid expansion of single-cell technologies, analytical complexity outpaced the capabilities of existing tools. Researchers relied heavily on manual gating and ad hoc workflows, limiting reproducibility and scalability. There was a clear gap between what the data contained and what the software ecosystem could extract in practice.",

    challenges:
      "Existing tools were not designed for high-dimensional data or extensibility. Analytical workflows were manual, error-prone, and difficult to reproduce across labs. Bridging this gap required working within the constraints of an established software ecosystem while introducing more rigorous, programmatic approaches.",

    approach:
      "Developed custom plugins and analytical tooling extending FlowJo, integrating statistical methods and automated workflows into existing analysis pipelines. Focused on usability for domain scientists while introducing more structured, reproducible approaches to data exploration and interpretation.",

    role:
      "Designed and implemented the analytical methods and software components. Worked directly with researchers to translate practical needs into usable tools, combining software development, statistical modeling, and domain expertise.",

    impact:
      "Enabled researchers to move from manual, heuristic-driven analysis to more reproducible and scalable workflows. The plugin remains in use and has supported multiple published studies, contributing to broader adoption of more rigorous analytical approaches in single-cell research.",

    tags: ["Flow Cytometry", "Single-Cell", "R", "Statistical Modeling", "Scientific Software"]
  },
  {
    slug: "in-code-we-trust",
    title: "In Code We Trust: A Decade of Applied ML Writing",
    year: "2016 – Present",
    featured: true,
    oneLiner:
      "A long-running technical blog exploring machine learning, data analysis, and scientific computing through practical, hands-on work.",

    context:
      "Over the past decade, I have maintained a personal blog focused on machine learning, statistical analysis, and scientific programming. The goal was not content production, but to externalize thinking, working through real problems, documenting approaches, and making complex analytical concepts accessible through concrete examples. The work spans early-stage data exploration, statistical testing, and machine learning workflows.",

    challenges:
      "Maintaining consistency over a long time horizon while evolving technically. Early articles reflect the state of the field and my own development at the time, requiring continuous adaptation in both depth and perspective.",

    approach:
      "Articles were developed from first principles and practical use cases, combining code, methodology, and interpretation. The focus was consistently on clarity, reproducibility, and applicability rather than abstraction. Topics included statistical hypothesis testing, clustering validation, data wrangling, and the use of R for scientific computing. Several articles were directly tied to tools and packages I developed, creating a tight feedback loop between writing, coding, and real-world usage. Over time, the blog served as both a knowledge base and a platform for refining how complex technical ideas are communicated to different audiences.",

    role:
      "Author and developer. Defined topics, built accompanying code and tools, and iterated continuously based on real-world use and evolving expertise.",

    impact:
      "Built a body of work over 10+ years covering applied machine learning and data analysis, with articles used by practitioners in research and applied settings. More importantly, this work established a strong foundation in translating complex analytical concepts into usable frameworks, a capability that later extended into product, consulting, and AI system design.",

    tags: ["Machine Learning", "Data Science", "Scientific Computing", "Technical Writing", "R", "Statistics"]
  },
  {
  slug: "llm-feedback-loop-enterprise-ai",
  title: "Designing Feedback Loops for LLM Systems in Production",
  year: "2025-2026",
  featured: true,
  oneLiner:
    "Most enterprise AI systems fail because they don’t learn. This project implemented a structured feedback loop to close the gap between system output and user expectation.",

  context:
    "LLM-based knowledge systems often underperform in real-world environments. Not primarily due to model limitations, but because of a persistent gap between what the system returns and what users actually expect. In enterprise contexts, this gap is rarely measured. Feedback is unstructured, inconsistently captured, and not integrated into system improvement. As a result, systems stagnate despite continuous model iteration.",

  approach:
    "Designed and implemented a two-step performance framework to systematically identify and reduce this gap. First, a scoring mechanism was introduced to quantify the mismatch between system responses and user expectations across multiple knowledge domains. This transformed qualitative dissatisfaction into a measurable signal. Second, a lightweight, in-product feedback mechanism was deployed, allowing users to provide free-text input directly within their workflow. To ensure scalability and privacy, feedback was aggregated and summarized using LLM-based processing, producing structured insights without exposing individual user data. These insights were then used to iteratively refine prompts and retrieval strategies, establishing a continuous learning loop at the system level.",

  impact:
    "Initial iterations resulted in a consistent 10–15% improvement in response relevance across multiple knowledge managers. More importantly, the system introduced a scalable mechanism for continuous alignment between AI output and user expectations, addressing a core failure mode of enterprise AI systems.",

  challenges:
    "Capturing high-quality feedback without disrupting user workflows, while ensuring privacy and usability. Designing a system that produces actionable signals rather than noise, and integrating those signals into an iterative improvement loop without increasing operational complexity.",

  role:
    "Co-designed the performance framework and feedback architecture. Worked at the interface of product, engineering, and end users to translate qualitative feedback into measurable signals and system-level improvements.",

  tags: ["LLM Systems", "AI Product", "Feedback Loops", "Enterprise AI", "Human-in-the-Loop", "Prompt Engineering", "Information Retrieval"],
  }
];

export const articles = [
  {
    slug: "interfaces-are-the-bottleneck",
    title: "The Real Bottleneck Isn’t Models or Data. It’s Interfaces.",
    date: "2026-05-06",
    excerpt:
      "The gap between a new method and its real-world use is where most systems fail. It’s not about models. It’s about interfaces.",
    readingTime: "8 min",
  },
  {
    slug: "agentic-coding-collapses-costs",
    title: "Agentic Coding Collapses Build Costs. So Why Is Healthcare Software Still Hard?",
    date: "2026-05-13",
    excerpt:
      "When software creation becomes abundant, competitive advantage moves toward trust, workflow ownership, and operational control.",
    readingTime: "12 min",
  },
];

export const articleContent: Record<string, string> = {
  "interfaces-are-the-bottleneck": `
It’s the mid-2010s. I’ve already switched fields once, and I’m working in single-cell biology at a time when the discipline is in full ebullition. We’ve just gone from a handful of parameters to a few dozen. So naturally, I move from manual tools to writing my own pipelines. It feels like progress.

It was just the beginning.

## When Data Outpaced Software

I had the opportunity to work at a moment when single-cell biology began to outpace the software built to support it. The transition from protein measurements to RNA sequencing did not simply increase scale, it fundamentally altered the nature of analysis. Data moved from tens of parameters to tens of thousands.

The only viable approach was to rely on code written and maintained by bioinformaticians, loosely connected to the scientists generating the data. New algorithms appeared in the literature at high frequency, but their practical use lagged behind. Integration was slow, often brittle, and rarely aligned with how researchers actually worked.

I became in demand. And yet, it was not particularly satisfying.

### Methods proliferated rapidly. Software did not.

The constraint was not computational. Nor was it statistical. It was operational. And it was largely invisible to those building the tools. Most vendors responded by attempting to incorporate some methods directly into their products. One algorithm at a time, fully integrated, positioned as a definitive solution.

By the time a method was implemented, it was often no longer state of the art. More importantly, these systems imposed rigid workflows on users who neither needed nor wanted them. In a field defined by rapid iteration and intellectual autonomy, this rigidity was not a limitation. It was a structural flaw.

### A different approach

Rather than competing on the quality of individual methods, we focused on reducing the time between their appearance and their use in practice. That required a different architecture: one that allowed rapid integration, avoided premature standardization, and remained open to extension.

In practical terms, this meant treating software less as a product and more as an environment. The objective was not completeness. It was responsiveness.

## How Scientists Actually Think

This shift had consequences beyond engineering. It changed how we worked with users. Instead of delivering predefined pipelines, we spent time understanding how researchers actually structured their analysis.

A pattern emerged quickly: scientists do not think in pipelines. They think in questions. Tools that enforced linear workflows disrupted that process. Tools that allowed recombination and iteration supported it.

### One example stayed with me.

A research group was combining flow cytometry with single-cell sequencing, sorting live cells based on surface markers, then profiling them at the transcriptomic level. The problem was not generating data. It was reconciling it: matching low-dimensional phenotypic information with high-dimensional RNA profiles.

The underlying method was not conceptually complex, but no standard solution existed. The process relied on back-and-forth between teams, manual steps, and fragile scripts.

The solution emerged during a discussion. It was sketched informally and implemented shortly thereafter as a plugin. What mattered was not technical sophistication, but immediacy. A fragmented workflow became operational. People could run it, adjust it, and build on it.

It stopped being a discussion and became part of the analysis.

That is a different category of value.

### What actually scales

New methods emerged. Users needed them. Integration followed quickly.  Over time, this created a system with properties that competitors struggled to replicate: not because any individual component was superior, but because the overall structure enabled continuous adaptation.

By contrast, competing approaches remained constrained by their own design choices. Systems built around tightly integrated pipelines could not evolve at the same pace. Those that prioritized proprietary methods tended to overstate their generality.

In both cases, the failure mode was the same: the system could not keep up with the field.

This dynamic is not unique to computational biology.

## The Same Pattern in AI

A similar pattern is now visible in artificial intelligence.

The focus is on models: larger architectures, marginal gains, increasing specialization. Meanwhile, many organizations struggle to translate these advances into systems that are actually used. Models exist, data exists, but usage remains limited. 

The bottleneck lies in the layer that determines whether a model becomes part of a workflow, or remains a demonstration. That layer is still poorly understood, and often treated as an implementation detail. It isn’t. It is where most projects fail. Integrate them into workflows, and allow iteration without excessive friction.

### The reality of healthcare

This becomes particularly evident in regulated environments such as healthcare. Here, performance is only one variable. Systems must also be traceable, interpretable, and integrated into existing processes. You are not deploying a model. You are introducing a system into a constrained environment with real consequences.

Optimizing the model while deferring everything else is a common pattern. Integration comes later; often too late, if at all. The result is predictable: technically sound solutions that never become operational. In fast-moving domains, the primary advantage is not better methods. It is reducing the time between a new idea and its use.

That requires **systems that are extensible, aligned with how people work, and capable of integrating change without friction**.

## Closing

It’s now the mid-2020s. Shimon Sakaguchi is being recognized for his work on regulatory T cells. Years earlier, I started coding to analyze those same cells, long before their significance was widely appreciated. The science has moved forward, as it always does.

Some of the tools built along the way are still in use. The plugin remains available, still works, and has supported published research.

The question is whether our systems keep up.
`,
  "agentic-coding-collapses-costs": `
In a previous piece, I argued that the real bottleneck in AI systems often lives at the interface between humans, workflows, and software rather than inside the model itself. Agentic coding pushes this shift even further. A few years ago, building serious software products in healthcare required sizable engineering organizations before you could even enter the conversation.

Today, that assumption is quietly breaking.

## The Cost Curve Snapped

Small teams equipped with increasingly agentic development workflows can prototype sophisticated applications in days rather than months. Requirements become executable. Documentation, testing, integration scaffolding, and implementation loops increasingly collapse into the same accelerated pipeline.

The mechanics of software production are changing rapidly, and in many ways for the better. But there is a mistake hidden inside the current excitement around agentic coding: many people assume that if software becomes dramatically cheaper to build, success automatically becomes easier.

In regulated industries like healthcare, the opposite may happen.

Because the hard part did not disappear. It simply moved. When build costs collapse, competitive advantage migrates elsewhere: toward distribution, governance, workflow integration, trust, and operational reliability.

## Cheap Build Does Not Mean Easy Success

Traditional software engineering largely optimized human implementation capacity: translating specifications through written code into execution.

Agentic workflows increasingly invert that relationship. The limiting factor becomes defining the right problem, constraining scope, and validating outputs.

The acceleration is not only in generation but also integration. Tool ecosystems and standardized interfaces increasingly reduce the friction of assembling complex systems. As generation and integration both accelerate, many people conclude that barriers to entry are disappearing altogether.

In regulated markets, that conclusion is often wrong.

### A working demo is not market entry

In consumer software, a functional product may already be enough to test adoption. Healthcare operates differently.

A prototype is not deployment.

A deployment is not adoption.

And adoption is not operational trust.

### The real barriers begin after the demo works.

Healthcare software is rarely evaluated as a standalone product. It is evaluated as part of a much larger operational system composed of procurement processes, interoperability constraints, clinical workflows, validation requirements, and organizational risk management.

In practice, this means the application itself is often the easiest part.

I have repeatedly seen technically impressive systems struggle not because the underlying capability was weak, but because integration into existing operational environments proved far harder than the original engineering effort.

The challenge was not simply building the software. It was earning the right to operate inside already complex systems.

### The app is no longer the moat

As agentic systems reduce the cost of producing features, features themselves become less defensible.

Competitive pressure shifts elsewhere: toward workflow ownership, operational guarantees, embedded distribution, governance, and trust accumulated over time.

The moat increasingly stops being the application itself. It becomes the permission to operate.

## Where The Barriers Reappear

### Barrier #1 — Distribution

The best software in the world, however cheap, still loses if nobody encounters it inside their existing workflow.

I saw a similar dynamic years ago during the expansion of high-dimensional single-cell analysis. Tasks that previously required highly specialized scripting or manual analysis became increasingly automated and accessible.

But greater technical accessibility did not eliminate operational concerns. The question increasingly became not only: “Can the system do this?”, but: “Under what constraints is this system allowed to act?”

This creates a paradox: even as building software becomes easier, gaining meaningful access to users may become harder. The more I work in regulated environments, the less I believe software capability alone determines adoption.

### Barrier #2 — Trust

Agentic systems introduce a new category of operational risk: autonomous or semi-autonomous execution inside critical environments.

In regulated environments, I’ve repeatedly seen technically impressive systems stall not because the underlying capability was weak, but because organizations could not operationalize trust around them.

The challenge was traceability, accountability, reproducibility, and integration into existing validation processes. Trust in healthcare is cumulative and asymmetrical. Reliability takes years to establish, while a single failure can destroy adoption.

In that context, autonomy is not merely a feature. It is a liability surface.

### Barrier #3 — Workflow integration

One lesson I’ve learned repeatedly in enterprise healthcare environments is that technically functional software and operationally adoptable software are often completely different products.

One of the most persistent misconceptions in AI is that adoption is primarily a model problem. In practice, many failures occur much later, during operational integration.

Healthcare systems are extraordinarily complex environments composed of fragmented data flows, legacy infrastructures, overloaded users, and tightly coupled operational processes.

In healthcare, the last mile is often most of the work. Adoption frequently becomes a systems integration problem wearing an AI costume.

## The New Moat

If software production becomes increasingly abundant, where does defensibility live? Increasingly, not in raw feature creation.

In regulated environments, competitive advantage starts accumulating around workflow ownership, operational trust, governance infrastructure, integration depth, and validated reliability over time.

Healthcare organizations rarely optimize for novelty alone. They optimize for continuity, accountability, and operational risk. This changes the competitive landscape significantly. The advantage shifts from:

> “Who can build?”

to:

> “Who can safely operate at scale?”

Paradoxically, cheaper software creation may strengthen some incumbents rather than weaken them, because distribution, trust, and workflow ownership become even more important once feature creation commoditizes.

## Build Is Becoming Abundant

Agentic coding represents a genuine structural shift in software creation.

Small teams can now produce capabilities that previously required far larger organizations. The economics of software production are changing rapidly. But in healthcare and other regulated industries, cheaper software creation does not eliminate barriers to entry. 

It relocates them. Toward trust. Toward workflow ownership. Toward governance, operational integration, and accumulated evidence over time. The more software creation becomes abundant, the more operational credibility becomes scarce.

The app is no longer the moat.

Operating permission is.
`
};
